MetaCap

CapsoVision (CV) vs Solana (HSDT)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

CapsoVision (CV) has outperformed Solana (HSDT) over the past year, gaining 16.8% versus a loss of 53.7%. CapsoVision is the larger company by market cap ($327.6 million vs $93.7 million), about 3.5 times the size, while Solana is growing revenue faster (+1057.1% vs +15.3%). CapsoVision converts more of its revenue into profit, with a net margin of -186.8% versus -679.6%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

CV+16.83%HSDT-53.73%
+188%+58%-72%
Nov 21, 20251 yearNov 20, 2026
CV+38.86%HSDT-84.15%
+215%+57%-101%
Jun 30, 20255 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

CV versus HSDT key metrics
MetricCVHSDT
Share price$6.11$1.49
Market cap$327.56M$93.70M
1-day change-3.17%-10.24%
YTD return-42.84%-48.44%
1-year return+16.83%-53.73%
5-year return—-100.00%
P/E ratio (TTM)—0.02
EPS (TTM)$-0.42$87.97
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$13.55M$6.02M
Revenue growth (YoY)+15.29%+1057.12%
Net income (latest FY)$-25.32M$-40.89M
Gross margin52.92%91.69%
Operating margin-188.25%-4052.52%
Net margin-186.77%-679.57%
52-week high$15.37$4.36
52-week low$4.50$1.19
Distance from 52-week high-60.25%-65.83%
Analyst consensusstrong_buystrong_buy
Avg. price target upside+55.48%+134.90%
Average volume173.59K579.67K
Shares outstanding53.61M62.89M
Employees9921
SectorHealth CareHealth Care
IndustryBiotechnology: Electromedical & Electrotherapeutic ApparatusBiotechnology: Electromedical & Electrotherapeutic Apparatus

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • CapsoVision is about 3.5 times larger than Solana by market value ($327.56M vs $93.70M).
  • CV has outperformed HSDT by 70.6 percentage points over the past year.
  • CapsoVision is more profitable, keeping -186.8 cents of every revenue dollar as net income versus -679.6 cents for Solana.
  • Solana grew revenue faster in its latest fiscal year (+1057.12% vs +15.29%).

About CapsoVision

CV stock →

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement of polyps, as well as develops CapsoColon 3D for large intestines (colon).

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 99 employees

About Solana

HSDT stock →

Solana Company operates as a listed digital asset treasury. The company enhances Solana tokens per share on the commercially viable blockchain for decentralized finance and consumer applications.

Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 21 employees

CV vs HSDT FAQ

Which is bigger, CapsoVision or Solana?

CapsoVision (CV) is larger, with a market capitalization of $327.56M compared with $93.70M for Solana (HSDT).

Which stock has performed better over the past year, CV or HSDT?

CV returned +16.83% over the past 12 months, compared with -53.73% for HSDT (price return, excluding dividends). Past performance does not predict future results.

Are CapsoVision and Solana in the same industry?

Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.

More comparisons